Financial Intelligence
Scored 11/1/2026
Buffett Quality
2.0/10
Lynch Category
Stalwart
Margin of Safety
—
Acquisition Risk
Not flagged
Owner Earnings
$5.0B
Recent Signals
20 foundREGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 219 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 27 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 192 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 105 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 121 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 55 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 376 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 454 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 380 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 224 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 74 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 38 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 271 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 279 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 66 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 25 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 50 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 463 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 127 · filing_date: 2026-10-15
10/15/2026
50%
REGENERON PHARMACEUTICALS, INC.
is_buy: false · shares: 211 · filing_date: 2026-10-15
10/15/2026
50%
Watch Reason
S&P 500 / major index component — seeded via EDGAR